Imperative Care · 7 hours ago
Clinical Data Management & Biostatistics Intern
Imperative Care is changing the way ischemic stroke, pulmonary embolism, and peripheral vascular disease are treated. The Clinical Data Management and Biostatistics Intern will support data management and analysis activities for clinical studies, providing hands-on clinical research experience in a regulated medical device environment.
Health CareMedicalMedical Device
Responsibilities
Reviewing clinical study data for completeness, consistency, and accuracy
Generating reports and data listings to guide clinical study monitoring activities
Writing code to automate report generation and perform statistical analyses
Generating summary tables, figures, and graphics for presentations and publications
Qualification
Required
At least 2 years of university level coursework completed towards a science related discipline (e.g., Data Science, Statistics, Biostatistics, Biomedical Engineering, Public Health)
Proficient with Excel and at least one programming language (R and Python preferred)
Proficient with statistical methods for analyzing and summarizing data
An eye for detail and pattern recognition
Preferred
Experience with electronic databases, data querying and manipulation a plus
Benefits
Ongoing networking
Learning and professional development opportunities
Mentorship from executive leadership
Social activities
Peer-to-peer interaction
Company
Imperative Care
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
H1B Sponsorship
Imperative Care has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (3)
2023 (5)
2021 (1)
Funding
Current Stage
Late StageTotal Funding
$558.97MKey Investors
Ally Bridge GroupD1 Capital Partners
2024-07-25Series E· $150M
2021-07-15Series D· $260M
2021-01-01Debt Financing· $40M
Recent News
BioWorld Financial Watch
2025-09-24
Company data provided by crunchbase